Professor Bernard Prendergast (Consultant Cardiologist, London Bridge Hospital, London, UK) discusses percutaneous mitral valve repair and mitral valve regurgitation, with particular emphasis on the results of the MITRA-FR trial and the MitraClip device.
Filmed at ESC 2018, Munich.
View more content here.
Speaker Disclosure: Professor Bernard Prendergast has nothing to disclose in relation to this video interview.
Questions:
1. What are the potential advantages and disadvantages of percutaneous mitral valve repair with MitraClip over optimal medical therapy for mitral valve regurgitation? (0:08)
2. What features of the MITRA-FR trial represent an improvement over previous studies assessing percutaneous mitral valve repair as a therapeutic option for mitral valve regurgitation? (1:00)
3. Please summarise the key results of the MITRA-FR trial? (2:02)
4. How do you determine which patients may be suitable for MitraClip? (2:59)
5. What are the short- and long-term goals for the treatment of mitral valve regurgitation? (3:41)
6. How was the study designed? (4:32)
touchCARDIO.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via open-access content in multimedia formats.
